BRCA2 gene mutation in cancer
- PMID: 36397405
- PMCID: PMC9666215
- DOI: 10.1097/MD.0000000000031705
BRCA2 gene mutation in cancer
Abstract
Breast cancer susceptibility gene 2 (BRCA2) is the main gene associated with hereditary breast cancers. However, a mutation in BRCA2 has also been found in other tumors, such as ovarian, pancreatic, thyroid, gastric, laryngeal, and prostate cancers. In this review, we discuss the biological functions of BRCA2 and the role of BRCA2 mutations in tumor progression and therapy.
Copyright © 2022 the Author(s). Published by Wolters Kluwer Health, Inc.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures
References
-
- Shiyu G, Jingyi Y, Liang L, et al. Analysis of the mutation status of genetic susceptibility genes in 116 cases of epithelial ovarian can. Chin J Eugenics Genet. 2021;29:1–5.
-
- Menghui L, Juntian L. Implication of BRCA1/2 gene detection in malignant tumors. Chin J Clin Oncol. 2019;46:361–5.
-
- Haijuan Y, Qiubai L, Jie F, et al. The BRCA2 homologue Brh2 nucleates RAD51 filament formation at a dsDNA-ssDNA junction. Nature. 2005;433:653–7. - PubMed
-
- Lepakshi R, Howard SM, Petr C. Main steps in DNA double-strand break repair: an introduction to homologous recombination and related processes. Chromosoma. 2018;127:187–214. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
